![Julio Font](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Julio Font
Chief Executive Officer at Noray Bioinformatics SL
Julio Font active positions
Companies | Position | Start | End |
---|---|---|---|
Noray Bioinformatics SL
![]() Noray Bioinformatics SL Packaged SoftwareTechnology Services Noray Bioinformatics SL develops software products for the biosciences sector. It offers support to the biosciences sector: Biotechnology, Biomedicine, and Bipharmacy. The company was founded by Julio Font in 2002 and is headquartered in Derio, Spain. | Chief Executive Officer | 2002-10-20 | - |
Founder | 2002-10-20 | - | |
Histocell SL
![]() Histocell SL BiotechnologyHealth Technology Histocell SL manufactures and develops cell therapy drugs. The firm specializes in the development of cell therapy drugs that treat conditions such as spinal cord injuries, idiopathic pulmonary fibrosis, scar tissue defects, and dermo-epidermal deficiencies. Its service portfolio encompasses cell therapy services for clinical applications, molecular and cellular biology analysis, biocompatibility tests, and biological research. The company was founded in 2004 and is headquartered in Derio, Spain. | Chief Executive Officer | - | - |
Career history of Julio Font
Statistics
International
Spain | 3 |
Operational
Chief Executive Officer | 2 |
Founder | 1 |
Sectoral
Technology Services | 2 |
Health Technology | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Private companies | 2 |
---|---|
Noray Bioinformatics SL
![]() Noray Bioinformatics SL Packaged SoftwareTechnology Services Noray Bioinformatics SL develops software products for the biosciences sector. It offers support to the biosciences sector: Biotechnology, Biomedicine, and Bipharmacy. The company was founded by Julio Font in 2002 and is headquartered in Derio, Spain. | Technology Services |
Histocell SL
![]() Histocell SL BiotechnologyHealth Technology Histocell SL manufactures and develops cell therapy drugs. The firm specializes in the development of cell therapy drugs that treat conditions such as spinal cord injuries, idiopathic pulmonary fibrosis, scar tissue defects, and dermo-epidermal deficiencies. Its service portfolio encompasses cell therapy services for clinical applications, molecular and cellular biology analysis, biocompatibility tests, and biological research. The company was founded in 2004 and is headquartered in Derio, Spain. | Health Technology |
- Stock Market
- Insiders
- Julio Font
- Experience